APA (7th ed.) Citation

I, Y., A, S., H, S., A, K., EF, M., PP, P., . . . G, V. (2026). Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study. Cancer, 132(1), e70210. https://doi.org/10.1002/cncr.70210

Chicago Style (17th ed.) Citation

I, Yasin, et al. "Characterization of Chromosome 5 Aberrations in TP53 Mutated Myeloid Neoplasms with ≥5% Blasts: An International TP53 Investigators Network (iTiN) Study." Cancer 132, no. 1 (2026): e70210. https://doi.org/10.1002/cncr.70210.

MLA (9th ed.) Citation

I, Yasin, et al. "Characterization of Chromosome 5 Aberrations in TP53 Mutated Myeloid Neoplasms with ≥5% Blasts: An International TP53 Investigators Network (iTiN) Study." Cancer, vol. 132, no. 1, 2026, p. e70210, https://doi.org/10.1002/cncr.70210.